Cargando…
Re-analysis of Genetic Risks for Chronic Fatigue Syndrome From 23andMe Data Finds Few Remain
Autores principales: | Bedford, Felice L., Greshake Tzovaras, Bastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012483/ https://www.ncbi.nlm.nih.gov/pubmed/33816394 http://dx.doi.org/10.3389/fped.2021.590040 |
Ejemplares similares
-
Comparison of Commercial Genetic-Testing Services in Korea with 23andMe Service
por: Kim, Sollip, et al.
Publicado: (2014) -
Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe
por: Lu, Mengfei, et al.
Publicado: (2017) -
23andMe: a new two-sided data-banking market model
por: Stoeklé, Henri-Corto, et al.
Publicado: (2016) -
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response
por: Li, Q S, et al.
Publicado: (2016) -
Incorporating functional priors improves polygenic prediction accuracy in UK Biobank and 23andMe data sets
por: Márquez-Luna, Carla, et al.
Publicado: (2021)